Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Molecular and Cellular Biology|April 1, 2003
Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotypeIna Poser, Michaela Golob, Reinhard Buettner, et al.Bioanalysis|December 3, 2015
An alternative design for long-term stability testing of large molecules: a scientific discussion paper from an EBF Topic TeamSusanne Pihl, Lene Andersen, Katharina Bruzelius, et al.BMC Clinical Pharmacology|October 22, 2010
Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulationBernd Liedert, Ulf Forssmann, Peter Wolna, et al.Cancer Research|October 18, 2002
Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expressionIna Poser, Michaela Golob, Michael Weidner, et al.Bioanalysis|July 29, 2025
Why traditional validation may fall short for artificial intelligence in bioanalysis: a perspective from the European Bioanalysis ForumPhilip Timmerman, Katja Zeiser, Connor Walker, et al.Bioanalysis|March 15, 2013
The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method ValidationPeter van Amsterdam, Arjen Companjen, Margarete Brudny-Kloeppel, et al.Bioanalysis|April 24, 2020
European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation periodPhilip Timmerman, Joanne Goodman, Michaela Golob, et al.Bioanalysis|October 29, 2019
EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assaysSusanne Pihl, Barry Wa van der Strate, Michaela Golob, et al.Bioanalysis|April 8, 2014
Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBFJohn Smeraglia, Stuart McDougall, Karen Elsby, et al.Bioanalysis|November 6, 2025
Beyond contracts: principles for Pharma-CRO collaboration from the European Bioanalysis ForumPhilip Timmerman, Matthew Barfield, Lee Goodwin, et al.Pageof 3